SABARI SECURITIES(@sabarish091282) 's Twitter Profile Photo

Today results for some key stocks which I believe they all will come out with stellar set 👍 let’s see

1. SBI
2. ITC
3. Zydus life science
4. KIMS
5. Ujjivan financial services

account_circle
Kueez(@Kueez1) 's Twitter Profile Photo

With these maps, we can now better understand things that were previously difficult to comprehend.

account_circle
RedboxGlobal India(@REDBOXINDIA) 's Twitter Profile Photo

ZYDUS LIFESCIENCES: Q4 CONS NET PROFIT RUPEES 3B VS 4B (YOY); EST 7.14B | 6.23B (QOQ)

MISSES EST
POOR YOY
POOR QOQ

account_circle
Rohit Saini(@rohits_bn) 's Twitter Profile Photo

Upcoming results today

Zydus Lifesciences Ltd
Trident Ltd
PSP Projects Ltd
Kamdhenu Ltd
G R Infra
Clean Science
Sumitomo Chem
Rites Ltd
Man Ind
State Bank of India
Jet Airways
Universal Cables
United Spirits
P I Ind
Ramco Cements
L T Foods Ltd
ITC Ltd
GAIL Ltd
Century Enka…

account_circle
polymath(@dforensicsguy) 's Twitter Profile Photo

Now the good news is Rhonda’s favourite probiotic supplement VSL # 3 and its successor, Visbiome are sold in India by Sun Pharma and Zydus Cadila respectively.

The bad news is that unless you’re suffering from Crohn’s disease or Ulcerative Colitis, it won’t do much for you.

Now the good news is Rhonda’s favourite probiotic supplement VSL # 3 and its successor, Visbiome are sold in India by Sun Pharma and Zydus Cadila respectively.

The bad news is that unless you’re suffering from Crohn’s disease or Ulcerative Colitis, it won’t do much for you.
account_circle
RedboxGlobal India(@REDBOXINDIA) 's Twitter Profile Photo

ZYDUS LIFESCIENCES: Q4 EBITDA RUPEES 12.55B VS 7.18B (YOY); EST 10.66B || Q4 EBITDA MARGIN 25.06% VS 18.6% (YOY); EST 22.5%

BEAT EBITDA AND MARGINS

account_circle
CNBC-TV18(@CNBCTV18Live) 's Twitter Profile Photo

| Zydus Life to report results today where the street is expecting numbers to be supported by a lower base. US estimate at $230 m to $254 m vs $235 m on quarterly basis supported by sales of Revlimidgeneric (cancer drug) + launch of Trokendigeneric.

#4QWithCNBCTV18 | Zydus Life to report #Q4FY23 results today where the street is expecting numbers to be supported by a lower base. US estimate at $230 m to $254 m vs $235 m on quarterly basis supported by sales of Revlimidgeneric (cancer drug) + launch of Trokendigeneric.
account_circle
Beat The Street(@BeatTheStreet10) 's Twitter Profile Photo

All 3 SugarFree products from Zydus Wellness have ingredients which WHO has identified as a potential risk to human health

PS Zydus has 94% market share in sugar free industry

All 3 SugarFree products from Zydus Wellness have ingredients which WHO has identified as a potential risk to human health

PS Zydus has 94% market share in sugar free industry
account_circle
Zydus(@Kingnidhin28) 's Twitter Profile Photo

BitLife So Bitlife here me out (11)
How about A vigilante Section........not a special career but a seperate section like crime......we could do crime fighting of course non legal like vigilantes like a real life 'batman' . Yes police could catch us too but less frequently than crime.

account_circle